The Senate and House approved a bill to establish a National Clinical Care Commission within HHS to improve care coordination and prevention for patients with metabolic syndrome and autoimmune diseases related to insulin.
The conditions targeted in the bill, which include high blood pressure, obesity and high blood sugar, represent a significant disease burden in the U.S., as they greatly increase the risk of heart disease, stroke and diabetes. The commission created by the bill would evaluate federal prevention programs to identify gaps in support for providers, consolidate overlap, and improve education and treatment.
The commission is tasked with creating a plan of action within 90 days and finishing its work by 2021. With approval from both chambers of Congress, the bill will now be sent to the president for a signature.
More articles on population health:
Acting HHS Secretary Hargan declares a public health emergency in California due to fires
Propeller Health releases API to predict asthma conditions
Employees of small companies less likely to be screened for cancer, study finds